Business Focus
Clinical Focus
Spotlight
Academy
CME/CE
Job Board
Subscribe
- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
UPDATE: Fast Facts
Rising cost of prescription drugs
Fast Facts
40
Percentage of corporate executives who think direct-to-consumer advertising is most responsible for the rising cost of prescription drugs.
25
Percentage who think the expense of developing new drugs is most to blame.
Percentage who think the aging population is the No. 1 cause.
Source: 2004 Arxcel Prescription Benefit Research Survey
UPDATE: Fast Facts.
Medical Economics
Sep. 3, 2004;81.
Related Videos
Related Content
